The U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat certain types of bacterial ...

Veterinarians should become familiar with new definitions and recommendations for managing urinary tract infections in dogs ...

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...

Recurrent urinary tract infections affect kidney function in children with vesicoureteral reflux. Antibiotics can protect ...

This is the first approved indication for Orlynvah and the first FDA-approved product for Iterum. "We are so pleased to have achieved this historic milestone and would like to thank all the patients, ...

Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...

The FDA granted Priority Review to gepotidacin for the treatment of female adults and adolescents with uncomplicated UTI.

The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) ...

The clinical-stage pharmaceutical company said Friday that the Food and Drug Administration has approved its new drug application for Orlynvah as a treatment for uncomplicated urinary tract infections ...

Iterum Therapeutics (NASDAQ:ITRM) stock shot up 54% Friday after the company received FDA approval for its drug Orlynvah for ...

A YOUNG woman who thought nothing of her urinary tract infection (UTI) was later told she in fact had cancer and thought she might die. Katie Arding, 29, had just settled down on the Gold ...

Corey Fishman, CEO of Iterum, expressed pride in achieving this FDA approval, emphasizing the drug’s potential to offer new hope for patients dealing with difficult-to-treat infections. The ...